15.12.2012 Views

Registration Document - Pernod Ricard

Registration Document - Pernod Ricard

Registration Document - Pernod Ricard

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

4 Notes<br />

82<br />

ANNUAL CONSOLIDATED FINANCIAL STATEMENTS<br />

to the annual consolidated fi nancial statements<br />

The data and assumptions used for the impairment test applied to goodwill and intangible assets with indefinite useful lives of Cash Generating<br />

Units (CGUs) are as follows:<br />

PERNOD RICARD<br />

Method used<br />

to determine<br />

the recoverable<br />

amount<br />

Carrying amount<br />

of goodwill<br />

at 30.06.2009<br />

Carrying amount<br />

of brands and other<br />

intangible assets<br />

at 30.06.2009<br />

Value in use<br />

Perpetual<br />

growth rate<br />

France<br />

237 584<br />

Discount rate<br />

7.33% From (1)% to +2.5%<br />

Europe<br />

Americas<br />

Value in use based<br />

on the discounted<br />

cash flow method<br />

1,603<br />

2,262<br />

3,111<br />

5,803<br />

8.35%<br />

8.39%<br />

From (1)% to +2.5%<br />

From (1)% to +2.5%<br />

Asia/Rest of the World 787 1,813 8.57% From (1)% to +2.5%<br />

A 0.5 percentage point increase in the discount rate would generate<br />

no additional impairment to the value of indefinite intangible assets<br />

and goodwill.<br />

Provisions for pensions and other post-employment benefits –<br />

As indicated in Note 1.18, the Group participates in defined benefit<br />

and defined contribution pension plans. In addition, provisions are<br />

also recognised in virtue of certain other post-employment benefits<br />

such as life assurance and medical care (mainly in the United States<br />

and the United Kingdom). The carrying amount of these provisions at<br />

the balance sheet date is set out in Note 16.<br />

These benefit obligations are based on a number of assumptions such<br />

as discount rates, expected returns on plan assets, average future<br />

salary increases, rate of employee turnover and life expectancy.<br />

These assumptions are generally updated annually. Assumptions<br />

used in the preparation of the financial statements for the year<br />

ended 30 June 2009 and their methods of determination are set out<br />

in Note 16. The Group considers that the actuarial assumptions used<br />

are appropriate and justified, however, changes that could be made to<br />

such actuarial assumptions in the future may have a material impact<br />

on the amount of the Group’s benefit obligations and on its results.<br />

A 25 basis point reduction in the discount rate at 30 June 2009<br />

would have an impact of around €132 million on the amount of the<br />

benefit obligation under the Group’s main benefit plans, which are<br />

in the UK and North America. A change of one point in the rate of<br />

increase of medical and healthcare expenses would have an impact of<br />

approximately €9 million on the amount of the benefit obligation in<br />

respect of post-employment medical and healthcare coverage.<br />

Deferred tax – As indicated in Note 1.21, the deferred tax assets<br />

recognised result mainly from tax loss carryforwards and from<br />

timing differences between the tax and book values of assets and<br />

liabilities. Deferred tax assets in respect of tax losses are recognised<br />

if it is probable that the Group will have future taxable profits against<br />

which such losses will be used. Assessment of the Group’s ability to<br />

use these tax loss carryforwards involves a significant degree of<br />

judgment. Analyses are carried out to conclude whether or not these<br />

tax loss carryforwards are likely to be usable in the future. At 30 June<br />

2009, the amount of deferred tax assets is €1,186 million and is set<br />

out in detail in Note 8.<br />

Provisions – As indicated in Note 16, the Group is involved in some<br />

litigation and claims arising in the ordinary course of its business. In<br />

some cases, the amounts requested by the claimants are significant<br />

and the legal proceedings can take several years. In this context,<br />

provisions are calculated on the basis of the Group’s best estimate of<br />

the amount that will be payable based on the information available<br />

(notably that provided by the Group’s legal advisors). Any change<br />

to assumptions can have a significant effect on the amount of the<br />

provision recognised. The carrying amount of these provisions at the<br />

balance sheet date is set out in Note 16.<br />

Judg ments – In the absence of standards or interpretations applicable<br />

to a specific transaction, Group Management uses its judgment to<br />

define and apply those accounting policies that will provide relevant<br />

and reliable information in the context of the preparation of the<br />

financial statements.<br />

6. Business combinations<br />

Business combinations completed as from 1 July 2004 are recognised<br />

according to the purchase accounting method, in application of IFRS 3<br />

(Business combinations). Identifiable assets, liabilities and contingent<br />

liabilities of the acquired entity are recognised at fair value at the date<br />

of acquisition, after an allocation period of a maximum duration of<br />

twelve months from the date of acquisition. Cost of acquisition is<br />

measured at the fair value of assets given, equity instruments issued<br />

and liabilities incurred or assumed at the date of acquisition, plus any<br />

costs directly attributable to the acquisition. The excess of the cost of<br />

acquisition over the Group’s share in the fair value of the identifiable<br />

assets, liabilities and contingent liabilities is recognised as goodwill<br />

and is subject to impairment tests, at least once a year and as soon<br />

as there is an indication that it may be impaired. Goodwill relating<br />

to the acquisition of foreign entities is denominated in the functional<br />

currency of the acquired activity .<br />

7. Goodwill and intangible assets<br />

Goodwill – Goodwill is subject to an impairment test at least once<br />

a year and as soon as there is an indication that its value may have<br />

been impaired. To perform these tests, goodwill is allocated by<br />

geographical area on the basis of asset groupings at the date of each<br />

business combination. These asset groupings correspond to groups of<br />

assets which jointly generate identifiable cash flows that are largely<br />

independent. The methods and assumptions used for impairment<br />

tests in respect of these asset groupings are set out in Note 1.9. If<br />

impairment is identified, an impairment loss is recognised in profit<br />

and loss for the financial year.<br />

Intangible assets – Intangible assets are measured at cost on initial<br />

recognition. With the exception of assets with indefinite useful<br />

lives, they are amortised on a straight-line basis over their period<br />

of use, which is generally less than five years, and are written down<br />

when their recoverable amount is less than their carrying amount.<br />

Amortisation of intangible assets is recognised within operating<br />

profit in the income statement.<br />

I REFERENCE DOCUMENT 2008/2009 I

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!